Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment.

Literature DB >> 16683176

Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment.

Maria G Tektonidou¹, John Serelis, Fotini N Skopouli.

Abstract

Antitumor necrosis alpha agents have been successfully used for the treatment of rheumatoid and seronegative arthritis, Crohn's disease, psoriasis, and severe cases of vasculitis. Several side effects have been observed in patients receiving these agents including hypersensitivity reactions, infections, drug-induced lupus, or demyelinating syndromes. The presence of peripheral neuropathy has been reported only in isolated cases. We describe two cases of peripheral neuropathy which occurred in patients with rheumatoid arthritis receiving infliximab treatment, one with multifocal motor neuropathy with conduction block and another with axonal sensory polyneuropathy, reversed upon discontinuation of infliximab and intravenous gammaglobulin treatment.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2006 PMID： 16683176 DOI： 10.1007/s10067-006-0317-z

Source DB: PubMed Journal: Clin Rheumatol ISSN： 0770-3198 Impact factor: 2.980

16 in total

Review 1. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?

Authors: W H Robinson; M C Genovese; L W Moreland
Journal: Arthritis Rheum Date: 2001-09

2. Severe polyneuropathy complicating active Crohn's disease: rapid response to Infliximab.

Authors: S Rodinò; N Saccà; T D'Amico; A Fragomeni; A Giglio
Journal: Gut Date: 2003-07 Impact factor: 23.059

3. Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy.

Authors: C Rodriguez-Escalera; J Belzunegui; L Lopez-Dominguez; C Gonzalez; M Figueroa
Journal: Rheumatology (Oxford) Date: 2005-01 Impact factor: 7.580

4. Acute neuropathy with multiple conduction blocks after TNFalpha monoclonal antibody therapy.

Authors: Oliver C Singer; Bettina Otto; Helmuth Steinmetz; Ulf Ziemann
Journal: Neurology Date: 2004-11-09 Impact factor: 9.910

5. Peripheral neuropathy in patients with systemic rheumatic diseases treated with leflunomide.

Authors: C Metzler; A C Arlt; W L Gross; J Brandt
Journal: Ann Rheum Dis Date: 2005-12 Impact factor: 19.103

6. Multifocal motor neuropathy during treatment with infliximab.

Authors: Dario Cocito; Bruno Bergamasco; Alessia Tavella; Fabio Poglio; Ilaria Paolasso; Paolo Costa; Palma Ciaramitaro; Gianluca Isoardo
Journal: J Peripher Nerv Syst Date: 2005-12 Impact factor: 3.494

7. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study.

Authors: A E Voskuyl; A H Zwinderman; M L Westedt; J P Vandenbroucke; F C Breedveld; J M Hazes
Journal: Ann Rheum Dis Date: 1996-03 Impact factor: 19.103

8. Drug-induced systemic lupus erythematosus associated with etanercept therapy.

Authors: Najia Shakoor; Margaret Michalska; Charlotte A Harris; Joel A Block
Journal: Lancet Date: 2002-02-16 Impact factor: 79.321

9. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents.

Authors: Niveditha Mohan; Evelyne T Edwards; Thomas R Cupps; Nancy Slifman; Jong-Hoon Lee; Jeffrey N Siegel; M Miles Braun
Journal: J Rheumatol Date: 2004-10 Impact factor: 4.666

10. Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series.

Authors: Stephen J Jarrett; Gaye Cunnane; Philip G Conaghan; Sarah J Bingham; Maya H Buch; Mark A Quinn; Paul Emery
Journal: J Rheumatol Date: 2003-10 Impact factor: 4.666

17 in total

1. Isolated motor conduction block associated with infliximab.

Authors: A W Michell; A Gaitatzis; J Burge; M M Reilly; R Kapoor; M Koltzenburg
Journal: J Neurol Date: 2012-02-18 Impact factor: 4.849

2. Bilateral diaphragmatic paralysis associated with the use of the tumor necrosis factor-alpha inhibitor adalimumab.

Authors: Mina Mecheal Benjamin; Alan William Martin; Randall Lee Rosenblatt
Journal: Proc (Bayl Univ Med Cent) Date: 2014-04

3. Infliximab-associated neuropathy in RA patients--the importance of considering the diagnosis of mononeuritis multiplex.

Authors: J Birnbaum
Journal: Clin Rheumatol Date: 2006-10-25 Impact factor: 2.980

4. Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis.

Authors: Przemyslaw J Kotyla; Bogna Sliwinska-Kotyla; Eugene J Kucharz
Journal: Clin Rheumatol Date: 2007-06-05 Impact factor: 2.980

5. A case of spontaneously recovering multifocal motor neuropathy with conduction blocks (MMNCB) during anti-TNF alpha therapy for ankylosing spondylitis.

Authors: Giuseppe Paolazzi; Susanna Peccatori; Francesco P Cavatorta; Alberto Morini
Journal: Clin Rheumatol Date: 2009-04-07 Impact factor: 2.980